Cancer Therapeutics and Supportive Care Drug Industry and Market studies Research Report 2017

1
Cancer Therapeutics and Supportive Care Drugs
Market Global Industry Analysis, Size, Share,
Trends and Forecast, 2017 2023
2
A latest report has been added to the wide
database of Cancer Therapeutics and Supportive
Care Drugs Market by Infinium Global Research.
This report studies the Cancer Therapeutics and
Supportive Care Drugs Market by type (cancer
therapeutics, supportive care drugs), by
distribution channel (hospital, retail) market
status and outlook of global and major regions,
from manufacturers, and end industries. The
objective of the study is to identify market
sizes of different segments countries in
recent years and to forecast the values for the
next six years. Cancer Therapeutics and
Supportive Care Drugs Market provides
opportunities in micro markets for stakeholders
to invest along with the detailed analysis of
competitive landscape, latest trends, and
product offerings of the major companies in the
Cancer Therapeutics and Supportive Care Drugs
Market. According to the report the Global Cancer
Therapeutics and Supportive Care Drugs Market is
projected to grow at a CAGR of 9.7 in terms of
value over the period of 2017-2023. The growth in
the world market is primarily driven by
significant contribution by North America
(Leading region) region to this market. New
treatment options have become available in the
past five years, and the surge of innovation is
expected to continue due to a robust pipeline of
drugs in clinical development by a large and
diverse group of pharmaceutical companies.
Innovations in the development of new drugs and
therapies, large number of new drugs entering
into the market with FDA approval, increasing
prevalence of cancerous patients, availability
of new treatment options in the market and rise
in base of aging population are the key driving
factors for the growth of this market. In
addition, changing lifestyle habits of
populations, increased patients healthcare
awareness, and increasing demand for non-invasive
therapies are further expected to propel the
market growth in the coming years. Along with
these driving factors, the market for cancer
therapeutics is facing some challenges such as
time consuming regulatory compliance and high
cost of cancer drugs. However, the market for
cancer therapeutics and supportive care drugs is
likely to rise in the future due to the large
number of ongoing innovations for the treatment
of cancer. Geographically, North America is the
leading contributor to the market and is expected
to retain its position during the forecast
period due to high awareness, presence of large
base of cancer patients, rise in investments, and
various initiatives by government in the
healthcare sector. However, Asia-Pacific market
is expected to grow at a faster rate during the
forecast period. This is predominantly due to
increased healthcare awareness, technological
advancements, significant investments and
growing awareness among the population about the
treatment options available in the market.
3

• Companies profiled
• Abbott Laboratories,
• AstraZeneca plc,
• AstellasPharma Inc.,
• Bristol-Myers Squibb,
• Johnson Johnson,
• Eli Lilly,
• Novartis,
• Pfizer Inc.,
• Sanofi, AbbVie, Inc.,
• Teva Pharmaceuticals,
• Takeda Pharmaceuticals, etc.
• Click the Below Full Report Link -
  https//www.infiniumglobalresearch.com/healthcare_
  medical_devices/cancer_therapeutics_supportive_car
  e_drugs_mar ket
• Report Highlights
• The report delivers a strategic analysis of the
  global market for cancer therapeutics and
  supportive care drugs and growth forecast for
  the period from 2017 2023. The scope of the
  report includes competitive analysis of various
  market players who are operating in the market,
  segmental analysis based on type. It also covers
  geographical analysis of the market with growth
  forecast for the period of 2017 2023. The
  Porters Five Forces analysis and value chain
  analysis included in the report provides an
  insight into market dynamics and industry
  competition.
• Moreover, the report also includes growth
  strategies and entry barriers to be considered to
  cater to the exact business opportunities in
  this market. Additionally, to aid in strategic
  decision making, the report also includes
  competitive profiling of leading players, recent
  developments in the industry and various business
  strategies adopted by them. This report will help

4
players in global cancer therapeutics market to
plan and implement their strategies in different
market areas such as emerging geographies, and
new technologies. About Us Infinium Global
Research and Consulting Solutions is started with
a single motto of being business partner of first
choice. We at Infinium work on the strengths of
our clients to ensure we help them consolidate
their market position. We firmly believe in the
fact that if you are able to develop newer
opportunities then you find there is no dearth of
opportunities for you. With our strategic
research approaches and deep dive in the market
segments, we try to find out new opportunities
that our clients can encash with their existing
resources. Our experts with over 100 years of
cumulative experience in research offer the best
in the industry services to our clients to ensure
that they achieve their business goals. Browse
Detailed TOC, Description and Companies Mentioned
in Report _at_ https//www.infiniumglobalresearch.co
m/healthcare_medical_devices/cancer_therapeutics_s
upportive_care_drugs_mar ket